Cargando…
Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine photodynamic therapy disrupts redox homeostasis and induce mitochondria-mediated apoptosis in human breast cancer cells
Photodynamic therapy (PDT) is a clinically established and highly evolving treatment modality for cancer. PDT utilizes a light responsive drug called photosensitizer that selectively destroys tumor cells upon light irradiation. Squaraines are a class of dyes possessing all favorable characteristics...
Autores principales: | Saneesh Babu, P. S., Manu, Prasad M., Dhanya, T. Jayaram, Tapas, Pradhan, Meera, R. Nair, Surendran, Arun, Aneesh, Kumar A., Vadakkancheril, S. Jisha, Ramaiah, Danaboyina, Nair, S. Asha, Pillai, M. Radhakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294812/ https://www.ncbi.nlm.nih.gov/pubmed/28169351 http://dx.doi.org/10.1038/srep42126 |
Ejemplares similares
-
Picolyl Porphyrin Nanostructures as a Functional Drug
Entrant for Photodynamic Therapy in Human Breast Cancers
por: Marydasan, Betsy, et al.
Publicado: (2019) -
2-Amino-4-nitrophenol–1-(2,4,6-trihydroxyphenyl)ethanone (1/1)
por: Kocabıyık, Can, et al.
Publicado: (2012) -
Biocompatible Aza-BODIPY-Biotin
Conjugates for Photodynamic
Therapy of Cancer
por: Dutta, Dhiraj, et al.
Publicado: (2023) -
Polymorphism of p53 in cancer prognosis
por: Pillai, Radhakrishna Madhavan, et al.
Publicado: (2016) -
Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019)